Meeting Details

Schedule/Additional Info

Events

Pediatric Gynecology

Expiration Date:

March 31, 2029

Credits:

0.00 CREOG

The most common pediatric gynecologic problem is vulvovaginitis. This condition is an inflammation of the vulvar and vaginal tissue, and accounts for as many as 50% of outpatient pediatric gynecologic visits. This educational activity addresses the appropriate terminology of AUB, and identifies methods for patient communication and assessment to determine causal mechanisms and successfully treat this condition. The pediatric gynecologic problems, from birth to menarche, to be discussed in this module include vulvovaginitis, vulvar lesions, prepubertal vaginal bleeding, trauma, foreign bodies in the vagina, sexual abuse, abnormal pubertal development and ambiguous genitalia.

ACTIVITY NUMBER: RBP000

ACTIVITY TITLE: Pediatric Gynecology

ACCREDITATION STATEMENT

The American Society for Reproductive Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

ACTIVITY NUMBER: RBP000

ACTIVITY TITLE: Pediatric Gynecology

ACCREDITATION STATEMENT

The American Society for Reproductive Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Release Date: October 1, 2012

Expiration Date: March 31, 2029

Estimated Time to Complete Activity: 1.0 hour

NEEDS ASSESSMENT and IDENTIFICATION OF PRACTICE GAP

The most common pediatric gynecologic problem is vulvovaginitis. This condition is an inflammation of the vulvar and vaginal tissue, and accounts for as many as 50% of outpatient pediatric gynecologic visits. This educational activity addresses the appropriate terminology of AUB, and identifies methods for patient communication and assessment to determine causal mechanisms and successfully treat this condition. The pediatric gynecologic problems, from birth to menarche, to be discussed in this module include vulvovaginitis, vulvar lesions, prepubertal vaginal bleeding, trauma, foreign bodies in the vagina, sexual abuse, abnormal pubertal development and ambiguous genitalia.

EDUCATIONAL OBJECTIVES

At the conclusion of the educational activity, participants should be able to:

·         Describe gynecologic problems experienced by pediatric patients.

·         Desribe the key principles of a focused physical examination appropriate for the patient’s age.

·         Describe the indications for referral to a subspecialist

·         Identify and/or interpret selected tests to diagnose a specific gynecologic disorder in
a pediatric patient.

·         Determine the medical and surgical treatment of pediatric gynecologic disorders.

·         List the components of a forensic examination (including appropriate laboratory tests) to evaluate sexual abuse.

TARGET AUDIENCE

This activity is designed to meet the educational needs of resident physicians in obstetrics and gynecology and other related specialties.

ACGME COMPETENCIES

Medical Knowledge

Patient Care

Interpersonal and Communication Skills

SUCCESSFUL COMPLETION REQUIREMENTS

Successful completion of this educational activity requires the learner to:

·         View a course overview page, containing all CME and disclosure information, including acknowledgement of commercial support and disclosure of unlabeled use, prior to the start of
each module.

·         Complete a 10-question pre-exam prior to the module. Learners should note any pre-exam questions answered incorrectly for clarification during module study.

·         Be given the option of downloading a printed syllabus containing the presentation and narrative.

·         Participate in the interactive activity: Audio narration is synchronized with PowerPoint presentation that can be advanced, stopped or reversed as desired.

·         Complete a 10-question post-exam, with feedback of correct/incorrect answers, scoring a minimum of 70% in two attempts.

·         Complete the evaluation survey.

·         Print certificate of completion.

DISCLOSURE STATEMENT

It is the policy of ASRM to ensure balance, independence, objectivity, and scientific rigor in all its educational activities. All faculty/speakers participating in this activity are required to disclose any relationships they may have with companies whose products or services could be mentioned, allowing participants to determine the objectivity of the presentations. The content and views presented in this activity are those of the faculty/speakers and do not necessarily reflect those of ASRM. Any discussion of the off-label, experimental, or investigational use of drugs or devices is not allowed. The disclosure statements were reviewed by the CME Subcommittee and the Executive Program Committee of ASRM, and any perceived conflicts of interest were resolved in accordance with the ACCME’s policies and Standards of Integrity and Independence in Accredited Continuing Education.



PRIOR CONTRIBUTORS AND REVIEWERS

Ruben J. Alvero, MD – Nothing to Disclose

Alicia Y. Armstrong, MD – Nothing to Disclose

Valerie Baker, MD – Institutional Support from IBSA

Nancy A. Bowers, BSN, RN, MPH – Nothing to Disclose

Bruce R. Carr, MD – Research support from Wyeth, Neurocrine, Boehringer Ingelheim; Consultant for Novo Nordisk

Marcelle I. Cedars, MD – Nothing to Disclose

Marc Goldstein, MD – Advisory Board: Theralogix

Elizabeth A. Grill, PsyD – Nothing to Disclose

Andrew R. La Barbera, PhD, HCLD – Nothing to Disclose

Lawrence C. Layman, MD – Nothing to Disclose

Meredith Loveless, MD – Nothing to Disclose

Janet McLaren, MD – Nothing to Disclose

Patricia M. McShane, MD – Nothing to Disclose

Shona C. Murray, MD - Nothing to Disclose

Steven T. Nakajima, MD –Consultant, research support, speaker’s bureau for Warner Chilcott; Stockholder for IntegraMed

Staci E. Pollack, MD – Nothing to Disclose

Randal D. Robinson, MD - Speaker’s bureau for Merck and Teva

Richard H. Reindollar, MD – Nothing to Disclose

Nanette Santoro, MD – Consultant for QuatRx

James H. Segars, MD – Nothing to Disclose

Mary D. Stephenson, MD, MSc – Consultant for NoraTherapeutics

Kim L. Thornton, MD – Consultant for Parexel

James P. Toner, M.D., Ph.D. - Research support from Columbia Laboratories

Mark Trolice, MD – Cryos International – Paid Consultant (Self); Alto Pharmacy – Direct Stockholder (Self)

Ellen Wilson, MD – Nothing to Disclose

Bo Yu, MD – Nothing to Disclose



2025 CONTENT DEVELOPERS

Heather Burks – Pacific Coast Reproductive Society – Board of Directors (Self)

LaTasha Craig — Ferring Pharmaceuticals – Paid Consultant (Self)

Rani Fritz, MD – Cradle Genomics – Medical Advisory Board (Self)

Ryan Heitmann – Nothing to Disclose

Sarah Hmaidan – Nothing to Disclose

Bradley S. Hurst, MD – Nothing to Disclose

Patricia Jiminez, MD – Society for Reproductive Investigation – Member of DEI, Early Career, and CME committee*

Molly Kornfield – Nothing to Disclose

Dab Lebovic – Ferring Pharmaceutical – Paid Consultant (Self)

Nora Miller, MD – Nothing to Disclose

Ariya Mobaraki, MD – Nothing to Disclose

Amalia Namath, MD – Nothing to Disclose

Chioma Ogbejesi – Nothing to Disclose

Pamela Parker, MD – Nothing to Disclose

Jensen Reckhow, MD – Nothing to Disclose



2025 COURSE REVIEWERS (* beta-test participant reviewer; not responsible for content)

Heather Hipp, MD – Nothing to Disclose

Paul Lin, MD – Nothing to Disclose

Pamela Parker, MD – Nothing to Disclose

Divah Shah, MD – Nothing to Disclose

Mark Trolice, MD – Cryos International – Paid Consultant (Self); Alto Pharmacy – Direct Stockholder (Self)

David Walker, MD – Nothing to Disclose

Morgan Wiley, MD – Nothing to Disclose*



ADDITIONAL PRESENTERS AND RESOURCES

David Lee, MD – Nothing to Disclose



ASRM STAFF PLANNERS AND DEVELOPERS

Deidra Cain, DrPH, EdD – (former staff)

Michelle Landrum, EdD – (former staff)

Chevis Shannon, DrPH, MBA – Nothing to Disclose

Harriet Smith, M.Ed - Nothing to Disclose



STATEMENT OF SUPPORT

No commercial support has been provided for this activity.

It is the policy of the ASRM to ensure balance, independence, objectivity, and scientific rigor in all its educational activities. All faculty/authors participating in this activity were required to disclose any relationships they may have with commercial entities whose products or services are used to treat patients so that participants may evaluate the objectivity of the presentations. The content and views presented in this activity are those of the faculty/authors and do not necessarily reflect those of the ASRM or CREOG. Any discussion of off-label, experimental, or investigational use of drugs or devices will also be disclosed. The disclosure statements were reviewed by the Subcommittee for Standards of Commercial Support of the CME Committee of ASRM and any perceived conflicts of interest were resolved in accordance with the policies of the ACCME.

STATEMENT OF SUPPORT

No commercial support has been provided for this activity.

View More

View Less

List Price: Free

Login Required